Company Overview
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Company Information
- CEO
- Jonathan J. Mazelsky
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 11000
Contact Information
- Website
- https://www.idexx.com
- Address
- One IDEXX Drive
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 50.94B market capitalization
- Trading Volume: 389.43K shares traded today
- Price Range: 52-week range of $356.14 - $688.12
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. (IDXX) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 50.94B, the company represents a significant player in its market. The stock is currently trading at $636.71 with a negativedaily change of 0.18%.
The company's 11000 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 52.93, beta of 1.50, and 52-week price range from $356.14 to $688.12when evaluating investment opportunities.
Why Invest in IDEXX Laboratories, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Jonathan J. Mazelsky
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.